
### [MONDO:0016341](http://purl.obolibrary.org/obo/MONDO_0016341)
**Label:** lysosomal disease with restrictive cardiomyopathy

**Subclasses:** [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), 

**Mapped go classes:** [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity), [GO:0048878](http://purl.obolibrary.org/obo/GO_0048878) (chemical homeostasis), [GO:0002086](http://purl.obolibrary.org/obo/GO_0002086) (diaphragm contraction), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0009311](http://purl.obolibrary.org/obo/GO_0009311) (oligosaccharide metabolic process), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0051001](http://purl.obolibrary.org/obo/GO_0051001) (negative regulation of nitric-oxide synthase activity), [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0045019](http://purl.obolibrary.org/obo/GO_0045019) (negative regulation of nitric oxide biosynthetic process), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0046477](http://purl.obolibrary.org/obo/GO_0046477) (glycosylceramide catabolic process), [GO:0006941](http://purl.obolibrary.org/obo/GO_0006941) (striated muscle contraction), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0006027](http://purl.obolibrary.org/obo/GO_0006027) (glycosaminoglycan catabolic process), [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity), [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0030209](http://purl.obolibrary.org/obo/GO_0030209) (dermatan sulfate catabolic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0016139](http://purl.obolibrary.org/obo/GO_0016139) (glycoside catabolic process), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0005980](http://purl.obolibrary.org/obo/GO_0005980) (glycogen catabolic process), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity), [GO:0043181](http://purl.obolibrary.org/obo/GO_0043181) (vacuolar sequestering), [GO:0002026](http://purl.obolibrary.org/obo/GO_0002026) (regulation of the force of heart contraction), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), 

**Class expressions from DL-Learner:**

- Thing 53.32%
- [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity) 51.85%
- [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity) 51.85%
- [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity) 51.85%
- [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity) 51.85%
- [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity) 51.85%
- [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity) 51.85%
- [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity) 51.85%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 40.91%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 40.91%


